Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (147)
- Compliance and enforcement (36)
- Import and export (36)
- Shortages and supply disruptions (17)
- Sunscreens (10)
- Advertising (7)
- COVID-19 (5)
- Labelling and packaging (5)
- Weight loss products (5)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1316 result(s) found, displaying 551 to 575
-
Safety alertsThe counterfeit product named Placebo Tablets pose a serious risk to your health and should not be taken. They contain undeclared clenbuterol and have not been assessed for quality, safety or efficacy.
-
Market actionsHazard alert due to potential for under-drainage.
-
Safety alertsSafety advisory – not to be used in patients with compromised immune function
-
Safety alertsThis year, only quadrivalent vaccines will be available
-
Market actionsHazard alert due to increased risk of requiring revision.
-
Market actionsHazard alert due to potential for MRI scans to affect valve positioning.
-
Market actionsRecall for product correction due to potential loss of therapy due to power error.
-
Safety alertsZhen Gongfu capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.
-
Safety alertsImpeous Man capsules pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and phenolphthalein. They have not been assessed for quality, safety or efficacy.
-
Safety alertsChao Jimengnan Super Powerful Man Tablets pose a serious risk to your health and should not be taken. They contain undeclared sildenafil and have not been assessed for quality, safety or efficacy.
-
Safety alertsRecall - potential for adverse events related to aristolochic acid
-
Market actionsRecall due to risk of infection due to leakage.
-
Safety alertsSafety advisory - updated information about risk of blood clots
-
Safety alertsUpdate in relation to the safety and efficacy of low-dose codeine containing products
-
Safety alertsSafety advisory – risk of hepatitis B virus reactivation
-
Market actionsHazard alert due to potential for partial loss of therapy.
-
Market actionsHazard alert due to revision rate increasing.
-
Market actionsHazard alert - higher than expected rate of PE inlay breakage
-
Market actionsRecall for product correction - child-resistant caps may not function correctly
-
Safety alertsAlert - TGA advice regarding potential association with heart failure
-
Market actionsHazard alert due to potential for loss of telemetry and pacing due to battery malfunction.
-
Safety alertsMultani Kamini Vidrawan Ras tablets and Ayurvedant Kamini Vidravan Ras tablets pose a serious risk to your health and should not be taken. They contain prescription-only substances.
-
Market actionsRecall – potential for adverse events related to aristolochic acid(s)
-
Market actionsHazard alert due to potential for implant failure due to loosening.
-
Market actionsHazard alert due to risks of leaks, stent movement and aneurysm enlargement.